Google News

AbbVie’s Diversification Bet Gradually Shows Results, While Pfizer Seeks a Second Takeoff Through Its GLP-1 and Oncology Pipelines - NAI500

Sep 5, 2026, 8:29 AM

Translate article text

Choose a language and wait for the translated text.

AbbVie’s Diversification Bet Gradually Shows Results, While Pfizer Seeks a Second Takeoff Through Its GLP-1 and Oncology Pipelines  NAI500